According to the Daily Mail, the FDA is currently reviewing data about another booster shot. Officials at the agency are also considering whether to make these second booster doses mandatory. In addition, they are weighing if these will signal the start of yearly COVID-19 injections, with signs pointing to a possible authorization.
As per guidance from the Centers for Disease Control and Prevention (CDC), immunocompromised Americans ought to get boosted against the B11529 omicron variant first discovered in South Africa. While more infectious than the earlier B16172 delta variant, omicron poses little risk to the general population with its mild symptoms.
Sara Middleton of NaturalHealth365 pointed out several issues with the COVID-19 vaccine boosters. According to her, the COVID-19 shots were sold to the public as “the only way to end the pandemic” and the best way to prevent COVID transmission. However, this was quickly proven to be false as the shots did not stop the transmission of the pathogen responsible for COVID-19.
She also noted how the COVID-19 vaccines have triggered a meteoric rise in adverse events reporting to the Vaccine Adverse Event Reporting System. Cardiac inflammation, blood clots and low platelet count are just some of the many adverse reactions linked to the vaccines.
“Wouldn’t the public also want to know that the CDC recently found that booster shots are not beneficial for people between the ages of 18 and 49? Why mandate a drug that has not been shown to be helpful? I thought we were supposed to ‘follow the science,’” said Middleton.
“This is also a drug that has been shrouded in secrecy by the very agencies tasked with researching its effectiveness and safety,” she added. Middleton referenced the CDC’s withholding of vaccine safety data for fears that it would lead to “misinformation” and “vaccine hesitancy” in her piece. (Related: CDC admits it withheld data from public to avoid spurring VACCINE HESITANCY.)
Formerly a possibility, fourth dose now a reality
Back in January, White House Chief Medical Advisor Dr. Anthony Fauci claimed that a fourth COVID-19 vaccine dose is “entirely conceivable.” He told ABC anchor Martha Raddatz during the Jan. 23 edition of “This Week”: “We may need to boost again; that’s entirely conceivable. But before we make that decision about yet again another boost, we want to determine clearly what the durability of protection is of that regular boost, that third shot.”
Months earlier, Fauci had also encouraged frequent booster vaccinations – as often as twice a year – during his November 2021 appearance on “This Week.”
“We would hope – and this is something we are looking at very carefully – that the third shot [will] not only boost you way up, but increases your durability. If it doesn’t and the data shows we do need it more often, then we’ll do it,” he said at the time.
Anti-corruption group Project Veritas revealed that the FDA is pushing hard for the fourth boosters in anticipation of a possible revenue stream. It released hidden recordings of FDA Medical Countermeasures Initiative Executive Officer Christopher Cole admitting in two separate instances that COVID-19 vaccination would become an annual occurrence.
“You’re going to have to get an annual shot. It hasn’t been formally announced yet because they don’t want to rile everyone up,” Cole revealed in a recording from January.
The FDA official admitted in a February recording: “[President Joe] Brandon wants to inoculate as many people as possible. I think it’s going to be a gradual thing. Schools are going to mandate it.”
“The drug companies, the food companies, the vaccine companies – they pay us hundreds of millions of dollars a year to hire and keep the reviewers to approve their products. If they can get every person required [to get] an annual vaccine, that is a recurring return of money,” added Cole.
More related stories:
Watch Christopher Cole of the FDA revealing why the agency is pushing for the fourth COVID-19 vaccine dose below.
This video is from the Bright345 channel on Brighteon.com.
More stories like this can be found at FDA.news.